Development and Prospective Randomized Evaluation of a Decision Aid for Prostate-specific Antigen-based Early Detection of Prostate Cancer in Men Aged Between 55 and 69 Yr:The PSAInForm Trial

被引：2

作者：

Semjonow, Axel ^{[1
]}

Hense, Hans-Werner ^{[2
]}

Schloessler, Kathrin ^{[3
]}

Simbrich, Alexandra ^{[2
]}

Borowski, Matthias

Bothe, Christiane ^{[1
]}

Kruse, Klaus ^{[1
]}

Tiedje, Dorothee ^{[1
]}

Kuss, Kathrin ^{[3
]}

Adarkwah, Charles Christian ^{[3
,5
]}

Maisel, Peter ^{[6
]}

Jendyk, Ralf ^{[6
]}

Kurosinski, Marc-Andre

Gerss, Joachim ^{[4
]}

Heidinger, Oliver ^{[7
]}

Tschuschke, Christian ^{[8
]}

Becker, Ralf ^{[9
]}

Roobol, Monique J. ^{[10
]}

Bangma, Chris ^{[10
]}

Donner-Banzhoff, Norbert

机构：

[1] Univ Hosp Muenster, Prostate Ctr, Albert Schweitzer Campus 1, D-48149 Munster, Germany

[2] Westfalian Wilhelms Univ Muenster, Inst Epidemiol & Social Med, Munster, Germany

[3] Philipps Univ Marburg, Dept Gen Practice Family Med, Univ Marburg, Marburg, Germany

[4] Westfalian Wilhelms Univ Muenster, Inst Biostat & Clin Res, Munster, Germany

[5] Univ Siegen, Dept Hlth Serv Res & Gen Practice, Siegen, Germany

[6] Univ Hosp Muenster, Dept Gen Med, Munster, Germany

[7] Canc Registry North Rhine Westphalia, Bochum, Germany

[8] Landesverband Westfalen Lippe, Berufsverband Deutsch Urologen, Munster, Germany

[9] Hausaerzteverbund Muenster, Munster, Germany

[10] Erasmus Univ, Erasmus Univ Med Ctr, Dept Urol, Rotterdam, Netherlands

来源：

EUROPEAN UROLOGY | 2019年 / 76卷 / 01期

关键词：

D O I：

10.1016/j.eururo.2019.01.008

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1 / 3

页数：3

共 50 条

[31] Detection Rates of Nonpalpable Prostate Cancer in Korean Men With Prostate-specific Antigen Levels Between 2.5 and 4.0 ng/mL
Kim, Hong Seok
Jeon, Seong Soo
Choi, Jae Duck
Kim, Wansuk
Han, Deok Hyun
Jeong, Byong Chang
Seo, Seong Il
Lee, Kyu Sung
Lee, Sung Won
Lee, Hyun Moo
Choi, Han Yong
UROLOGY, 2010, 76 (04) : 919 - 922
[32] EFFECT OF SEXUAL BEHAVIOR ON PROSTATE-SPECIFIC ANTIGEN LEVELS IN MIDDLE-AGED MEN SCREENED FOR PROSTATE CANCER: RESULTS FROM THE PROBASE TRIAL
Herkommer, Kathleen
Meissner, Valentin H.
Hollerer, Miriam
Kron, Martina
Schiele, Stefan
Albers, Peter
Arsov, Christian
Kuczyk, Markus
Imkamp, Florian
Hohenfellner, Markus
Schuetz, Viktoria
Gschwend, Juergen E.
JOURNAL OF UROLOGY, 2020, 203 : E1143 - E1143
[33] EFFECT OF SEXUAL BEHAVIOR ON PROSTATE-SPECIFIC ANTIGEN LEVELS IN MIDDLE-AGED MEN SCREENED FOR PROSTATE CANCER: RESULTS FROM THE PROBASE TRIAL
Meissner, V. H.
Hollerer, M.
Kron, M.
Schiele, S.
Albers, P.
Arsov, C.
Kuczyk, M.
Imkamp, F.
Hohenfellner, M.
Schutz, V
Gschwend, J. E.
Herkommer, K.
JOURNAL OF SEXUAL MEDICINE, 2020, 17 (06): : S161 - S162
[34] Individualized screening interval for prostate cancer based on prostate-specific antigen level - Results of a prospective, randomized, population-based study
Aus, G
Damber, JE
Khatami, A
Lilja, H
Stranne, J
Hugosson, J
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (16) : 1857 - 1861
[35] Gothenburg-2 study - PSA (prostate-specific antigen)-based prostate cancer screening with an early start before the age of 55
Wolframm, Benedikt
Huebner, Anne
Handke, Analena Elisa
Bushoff, Isabelle
Lakes, Jale
Al-Monajjed, Rouvier
Albers, Peter
Radtke, Jan Philipp
UROLOGIE, 2023, 62 (07): : 727 - 729
[36] Early dutasteride monotherapy in men with detectable serum prostate-specific antigen levels following radical prostatectomy: A prospective trial
Shin, Yu Seob
Lee, Jea Whan
Kim, Myung Ki
Jeong, Young Beom
Park, Seung Chol
INVESTIGATIVE AND CLINICAL UROLOGY, 2017, 58 (02) : 98 - 102
[37] Randomized trial finds that prostate cancer genetic risk score feedback targets prostate-specific antigen screening among at-risk men
Turner, Aubrey R.
Lane, Brian R.
Rogers, Dan
Lipkus, Isaac
Weaver, Kathryn
Danhauer, Suzanne C.
Zhang, Zheng
Hsu, Fang-Chi
Noyes, Sabrina L.
Adams, Tamara
Toriello, Helga
Monroe, Thomas
McKanna, Trudy
Young, Tracey
Rodarmer, Ryan
Kahnoski, Richard J.
Tourojman, Mouafak
Kader, A. Karim
Zheng, S. Lilly
Baer, William
Xu, Jianfeng
CANCER, 2016, 122 (22) : 3564 - 3575
[38] Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial
Tonttila, Panu P.
Lantto, Juha
Paakko, Eija
Piippo, Ulla
Kauppila, Saila
Lammentausta, Eveliina
Ohtonen, Pasi
Vaarala, Markku H.
EUROPEAN UROLOGY, 2016, 69 (03) : 419 - 425
[39] The GoTEBORG prostate cancer screening 2 trial: a prospective, randomised, population-based prostate cancer screening trial with prostate-specific antigen testing followed by magnetic resonance imaging of the prostate
Kohestani, Kimia
Mansson, Marianne
Godtman, Rebecka Arnsrud
Stranne, Johan
Wallstrom, Jonas
Carlsson, Sigrid
Hellstrom, Mikael
Hugosson, Jonas
SCANDINAVIAN JOURNAL OF UROLOGY, 2021, 55 (02) : 116 - 124
[40] Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation
Xie, Wanling
Regan, Meredith M.
Buyse, Marc
Halabi, Susan
Kantoff, Philip W.
Sartor, Oliver
Soule, Howard
Berry, Donald
Clarke, Noel
Collette, Laurence
D'Amico, Anthony
Lourenco, Richard De Abreu
Dignam, James
Eisenberger, Mario
James, Nicholas
Fizazi, Karim
Gillessen, Silke
Loriot, Yohann
Mottet, Nicolas
Parulekar, Wendy
Sandler, Howard
Spratt, Daniel E.
Sydes, Matthew R.
Tombal, Bertrand
Williams, Scott
Sweeney, Christopher J.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (26) : 3032 - +

← 1 2 3 4 5 →